1,580 material Form 8-K filings that 1,317 companies we cover made with the SEC in July 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Caesars Entertainment director Courtney Mather has resigned from the company's Board of Directors, effective July 6, 2026, according to an 8-K filed July 7, 2026. The filing states the resignation is not the result of any disagreement with the company.
Courtney Mather resigned from the Board of Directors effective July 6, 2026.
Mather informed the Executive Chairman of the Board of his decision on July 6, 2026.
The filing states the resignation is not due to any disagreement with the company.
Civeo completed a private offering of $100 million in 4.50% convertible senior notes due 2031 on July 7, 2026, with an option for initial purchasers to buy up to an additional $15 million. The company used about $22.3 million of the net proceeds to repurchase 660,297 common shares and plans to use the rest to repay borrowings under its syndicated facility agreement.
Notes carry a 4.50% interest rate, payable semi-annually, and mature August 1, 2031
Net proceeds of about $96.2 million, after discounts and offering expenses
Initial conversion price of about $40.51 per common share; maximum of 2,962,080 shares issuable, or 3,406,392 if the option is fully exercised
Company may not redeem the notes before August 1, 2029, except for tax or cleanup redemptions
ResMed agreed on June 30, 2026 to sell its MatrixCare business to private equity firm Frazier Healthcare Partners for $490 million in cash, subject to closing adjustments. The company plans to use the proceeds to return capital to shareholders, including an accelerated share repurchase, and for general corporate purposes. The filing reiterates ResMed's fiscal 2026 outlook and says the full fiscal 2027 outlook will be given on August 6, 2026.
Buyer is Frazier Healthcare Partners; price is $490 million all-cash, subject to certain closing adjustments.
Deal is expected to close in the first quarter of fiscal 2027, subject to regulatory approvals and customary conditions.
MatrixCare had approximately $220 million of revenue and $55 million of non-GAAP operating profit in fiscal 2026, based on preliminary results.
Recently completed Noctrix acquisition is expected to add about $30 million of fiscal 2027 revenue and reduce non-GAAP diluted EPS by about $0.20.
Goldman Sachs BDC said it will report second quarter 2026 financial results after the market closes on Thursday, August 6, 2026, and hold an earnings conference call on Friday, August 7, 2026 at 9:00 am Eastern Time. The announcement is a scheduling notice and does not contain financial results.
Second quarter ended June 30, 2026 results to be released after market close on August 6, 2026
Earnings conference call set for 9:00 am Eastern Time on August 7, 2026
Listen-only and Q&A dial-in numbers provided, with an archived replay on the company website
CareDx completed the sale of its Lab Products business to Eurobio Scientific on June 30, 2026, and the acquisition of Naveris, maker of the NavDx cancer test, on July 1, 2026. The company will include Naveris in its consolidated results from the third quarter of 2026, and it plans to give financial impact details on the sale during its second quarter 2026 earnings call.
Eurobio sale closed June 30, 2026; the 8-K reports $171.7 million in cash, subject to customary adjustments, while the press release cites $171.2 million at closing.
Naveris acquisition closed July 1, 2026, for $161.8 million in cash, subject to adjustments, plus up to $100.0 million in contingent cash tied to 2026 and 2027 revenue milestones.
The press release says Naveris generated approximately $35 million in revenue in 2025 and that NavDx has Medicare coverage for HPV-driven head and neck and anal cancer MRD testing.
Financial statements of Naveris and pro forma information will be filed by amendment within 71 calendar days.
Iridium completed its acquisition of the remaining 61% of Aireon Holdings LLC on July 2, 2026, giving it full ownership of Aireon. The purchase price was approximately $366.7 million, with half paid in cash and the rest funded by a $183.36 million interest-free loan from the sellers, while Aireon's $154.7 million term loans now sit on Iridium's consolidated balance sheet. The filing also discloses cash retention awards for two executives tied to the pending Rocket Lab merger.
Purchase price of approximately $366.7 million, 50% paid in cash at closing on July 2, 2026
Sellers provided a $183.36 million interest-free term loan maturing one year after the closing date
Aireon's Term Loans had an aggregate principal balance of $154.7 million, maturing October 10, 2028
CFO Vincent J. O'Neill ($409,999.98) and CLO Kathleen A. Morgan ($873,036.32) received retention awards tied to the Rocket Lab merger agreement dated June 28, 2026
Oceaneering completed a private placement of $500 million of 6.875% senior notes due July 15, 2034 on July 6, 2026, and amended its senior secured revolving credit facility the same day. The notes satisfied the financing condition for a previously announced cash tender offer, and the amendment raised revolver commitments and extended their maturity, which the company says provides additional financial flexibility.
$500 million of 6.875% senior notes due July 15, 2034, sold to qualified institutional and non-U.S. buyers on July 6, 2026
Interest payable January 15 and July 15 each year, starting January 15, 2027; notes are unsecured senior obligations
Revolving credit commitments increased from $215 million to $345 million; maturity extended from 2027 to 2031
Financing condition for the cash tender offer described in the June 24, 2026 Offer to Purchase was satisfied on July 6, 2026
Praxis Precision Medicines entered a research collaboration and license agreement with Remagine Labs to develop an iontophoretic transdermal patch for ulixacaltamide, its essential tremor candidate. The company also made an equity investment in Remagine, and says the transdermal option could broaden the patient population and strengthen the drug's competitive position.
Agreement announced July 7, 2026, with Remagine Labs, Inc., a developer of electronically controlled transdermal drug delivery systems
Remagine's platform is designed for precise, multi-day active transdermal dosing of ulixacaltamide for essential tremor
Praxis made an equity investment in Remagine; the filing does not disclose the amount or financial terms
The patch is intended to complement the company's lead oral program for ulixacaltamide
UGI Energy Services, a wholly owned subsidiary of UGI, entered into a Fourth Amendment to its credit agreement on June 30, 2026, with HSBC Bank USA as administrative agent and as 2026 Refinancing Term Lender. The amendment sets the Applicable Rate at 2.00% per annum for SOFR loans and 1.00% for base rate loans. The filing is a routine refinancing update and does not report financial results or shareholder-level changes.
Amendment dated June 30, 2026, to the credit agreement originally dated August 13, 2019
Applicable Rate set at 2.00% per annum for SOFR loans and 1.00% per annum for base rate loans
HSBC Bank USA, N.A. serves as administrative agent and 2026 Refinancing Term Lender
Global Industrial Company and its subsidiaries signed Amendment No. 4 to their credit agreement with JPMorgan Chase Bank, N.A. on June 30, 2026. The amendment extends the facility's maturity date from October 19, 2026 to June 30, 2031, pushing the repayment deadline out about five years.
Amendment No. 4 dated June 30, 2026, amends the Third Amended and Restated Credit Agreement from October 28, 2016.
Maturity date moves from October 19, 2026 to June 30, 2031.
JPMorgan Chase Bank, N.A. is administrative agent, sole bookrunner and sole lead arranger.
Public Storage's Chief Operating Officer, Chris Sambar, resigned effective at the end of July 2026 to become Chief Enterprise Officer at T-Mobile. The company said the departure was not related to any disagreement over its operations, policies, or practices, and that operations leadership will report to CEO Tom Boyle until a permanent replacement is named.
Chris Sambar resigned on July 2, 2026, effective at the end of July 2026
He is joining T-Mobile as Chief Enterprise Officer
No disagreement with the company on operations, policies, or practices, according to the filing
Operations leadership will report directly to CEO Tom Boyle until a permanent replacement is identified
Quaker Houghton's Vice President, Corporate Controller and Principal Accounting Officer, Steven Dassing, resigned on June 30, 2026, effective July 22, 2026, to pursue another career opportunity, and the company says the resignation is not the result of any dispute. Executive Vice President and Chief Financial Officer Mr. Coler will also take on the Principal Accounting Officer role when Dassing's resignation takes effect, with no new compensatory arrangements.
Steven Dassing resigned as VP, Corporate Controller and Principal Accounting Officer on June 30, 2026, effective July 22, 2026
Dassing plans to pursue another career opportunity; the company states no dispute or disagreement was involved
CFO Mr. Coler, age 53, will serve as Principal Accounting Officer in addition to his CFO role
No new compensatory arrangements were entered into with Mr. Coler for the added role
MasTec entered a $700 million delayed draw term loan to help fund its planned acquisition of Electrical Specialists, Inc., d/b/a the Superior Group, and expanded its revolving credit commitments by $350 million to $2,250 million. The company also agreed to issue about 1,195,721 shares, valued at about $475 million, as partial acquisition consideration, which the filing says represents about 1.5% of outstanding shares.
Delayed draw term loan of $700 million: $400 million three-year tranche and $300 million four-year tranche, with Bank of America as administrative agent.
Revolving credit commitments increased by $350 million to an aggregate $2,250 million.
About 1,195,721 consideration shares valued at about $475,000,000, roughly 1.5% of outstanding shares after issuance, expected to close in the third quarter of 2026.
Director Manuel Benito Miranda appointed to the Board effective June 30, 2026, and to the Compensation Committee.
Unitil Corporation completed its purchase of Aquarion Water Company of New Hampshire and Abenaki Water Co. from the Aquarion Water Authority on June 30, 2026. The purchase price was $55.8 million, including about $13.7 million of assumed debt, and the company funded it with a term loan from Scotiabank under an amended and restated credit agreement. The company said the acquisition is expected to be earnings accretive over the long term, but the filing gives no figures for near-term results.
The acquired systems include about 150 miles of water distribution mains and serve about 11,000 customers in eight New Hampshire communities.
Purchase price was $55.8 million, including $13.7 million of assumed debt, plus about $0.6 million for estimated working capital and reimbursable capital expenditures.
The credit agreement includes a $50.0 million Tranche B loan for these acquisitions, with amounts due June 30, 2027; Unitil borrowed $42.7 million on June 30, 2026.
Amendment No. 4, dated June 30, 2026, limited the purchase to Aquarion Water Company of New Hampshire and Abenaki Water Co.
T-Mobile appointed Chris Sambar, formerly Chief Operating Officer at Public Storage and a two-decade AT&T veteran, as Chief Enterprise Officer, effective no later than October 14, 2026. Chief Business and Product Officer Michael J. Katz is leaving his role effective July 8, 2026, and will remain as a strategic advisor through December 2026. The filing reports no financial results, so the changes affect shareholders through leadership structure rather than current numbers.
Chris Sambar joins as Chief Enterprise Officer, effective no later than October 14, 2026, reporting to CEO Srinivasan Gopalan
Michael J. Katz, Chief Business and Product Officer, steps away effective July 8, 2026, and stays as strategic advisor through December 2026
André Almeida moves to Chief Marketing, Brand and Broadband Officer; Dr. John Saw expands his role to include product engineering and cybersecurity
RPC, Inc. entered into an Amended and Restated Credit Agreement dated June 30, 2026, with Bank of America, N.A. as administrative agent, covering a revolving line of credit of up to $100 million. The amendment extends the termination date for revolving loans from June 22, 2027 to June 30, 2031 and removes the SOFR Adjustment from pricing, which gives the company a longer borrowing window on the stated terms.
Revolving line of credit of up to $100 million, including a $35 million letter of credit sub-facility and a $35 million swingline sub-facility
Termination date for revolving loans extended from June 22, 2027 to June 30, 2031
SOFR Adjustment (10 to 25 basis points under the prior terms) removed from pricing
Agreement dated June 30, 2026; 8-K filed July 7, 2026, signed by CFO Michael L. Schmit
LifeStance Health Group said director Jeffrey Rhodes resigned from the board and all its committees effective immediately, and that the resignation was not due to any disagreement with the company. The board appointed Thurman Justice, Lori Goltermann and Safwan Shabab as directors to fill vacancies, a board change that is administrative in nature and carries no stated financial effect.
Jeffrey Rhodes resigned from the board and all committees effective immediately, notified July 2, 2026
Thurman Justice and Lori Goltermann appointed Class II directors, serving until the 2029 annual meeting
Safwan Shabab appointed Class III director under a June 9, 2021 stockholder agreement, serving until the 2027 meeting
Justice and Goltermann each received an initial award of 35,492 restricted stock units under the 2021 Equity Incentive Plan
ExxonMobil Holdings furnished a preview of factors it expects to affect 2Q 2026 results compared with 1Q 2026, including market effects, planned activity and Middle East disruptions. The filing does not give a total 2Q 2026 earnings estimate, and the company says the list is not comprehensive. Shareholders get a mix of favorable and unfavorable items, with final 2Q results due July 31, 2026.
Change in liquids prices is estimated to add $3.5 billion to $3.9 billion to 2Q 2026 results versus 1Q 2026.
Upstream impairments are estimated at $0.8 billion to $1.0 billion, and other items including reserves at $1.2 billion to $1.4 billion.
Middle East events are estimated to reduce Upstream results by $0.6 billion to $0.8 billion through volume-related disruptions.
The company plans to release 2Q 2026 results at about 5:30 a.m. CT on Friday, July 31, 2026.
Yext's board increased its size from seven to eight directors and elected Cynthia Paul, founder and CEO of investment firm Lynrock Lake LP, to fill the new seat as a Class I member. Her term runs to the 2027 annual meeting, and she receives standard outside director compensation including an initial restricted stock unit grant valued at $350,000.
Board expanded from seven to eight authorized directors; Paul elected July 7, 2026, with term expiring at the 2027 annual meeting.
Paul's initial grant is restricted stock units valued at $350,000, or 89,058 units, vesting in roughly equal annual installments over three years.
Outside directors also receive an annual award valued at $175,000 under the policy, and Paul signed the standard director and officer indemnification agreement.
Paul previously served on the boards of Allot Ltd., ON24, Inc. and DSP Group, Inc.
Genworth Financial said CEO Thomas McInerney is taking a temporary leave of absence to focus on his health. CFO Jerome Upton, who has been with the company since 1998, was named Interim President and Chief Executive Officer effective July 7, 2026. The filing does not describe how long the leave will last or any change to the company's strategy.
Thomas J. McInerney, President and CEO, began a temporary leave of absence on July 7, 2026 to focus on his health
Jerome T. Upton, 62, CFO since March 2023, was appointed Interim President and CEO effective July 7, 2026
Board Chair Melina Higgins said the company plans to continue executing its existing strategy during the interim period
Penguin Solutions reported third-quarter fiscal 2026 net sales of $478.7 million, up 48% from a year earlier, and GAAP diluted earnings of $0.68 per share compared with a loss of $0.01 per share. The company raised its full-year fiscal 2026 outlook for both net sales and earnings per share, citing AI-driven demand, which is a positive sign for shareholders on the company's headline measures.
Q3 fiscal 2026 net sales were $478.7 million, up from $324.3 million in the year-ago quarter; Integrated Memory sales were $275.1 million.
GAAP diluted EPS was $0.68 versus $(0.01) a year earlier; non-GAAP diluted EPS was $0.84 versus $0.47.
Full-year fiscal 2026 net sales growth outlook is now 22% plus or minus 2%, up from 12% plus or minus 5%; non-GAAP EPS outlook is now $2.60 plus or minus $0.05, up from $2.15 plus or minus $0.15.
Management will discuss results on a conference call and webcast today, July 7, 2026, at 1:30 p.m. Pacific Time.
Shawn Morris resigned from Privia Health Group's Board of Directors and its Compliance Committee, effective immediately, on July 6, 2026. The company said the resignation was not due to any disagreement over its operations, policies, or practices.
Resignation effective July 6, 2026, with immediate effect
Morris left the Board and the Compliance Committee of the Board
Company states no disagreement on operations, policies, or practices
Lifeway Foods entered into a Master Security Agreement with its current lender, CIBC Bank USA, on June 30, 2026, providing up to $22,000,000 in loan advances to finance or refinance equipment purchases. Advances convert into a five-year Equipment Guidance Line Note once the interim funding period ends, and the existing credit agreement terms remain unchanged. The filing describes a borrowing arrangement rather than an operating result, so it does not directly show a change in Lifeway's earnings.
Up to $22,000,000 in aggregate loan advances available during an interim funding period expiring June 30, 2027
Interest payable monthly at 1-month SOFR plus 1.65%, both during the interim period and after conversion
Advances convert to the Equipment Guidance Line Note, payable in monthly installments and maturing five years after the Conversion Date
Existing Credit Agreement with Fresh Made, Inc. and Lifeway Wisconsin, Inc. remains unchanged
Fiserv President Dhivya Suryadevara resigned for good reason effective July 7, 2026, and will remain a non-executive employee through July 31, 2026 to support an orderly transition. Andrew Gelb and Srini Krish were named interim leaders of the Financial Solutions business effective immediately, which shows the company is moving to fill the gap left by the departure.
Dhivya Suryadevara resigned as President on July 7, 2026, citing good reason under her offer letter and the company's executive severance policy.
Suryadevara stays on as a non-executive employee with current base salary and benefits through July 31, 2026.
Andrew Gelb (EVP and COO, Financial Solutions) and Srini Krish (Head of Technology and Operations, Financial Solutions) were appointed interim leaders effective immediately.
Farmers & Merchants Bancorp said its board decided on June 30, 2026 to appoint Gregory R. Allen to fill an open board seat, with his first meeting set for September 29, 2026. He will receive the same non-employee director pay as other board members, and the filing does not say which committees he will join.
Board appointed Gregory R. Allen to fill an open vacancy; decision made June 30, 2026
First board meeting for Mr. Allen scheduled for September 29, 2026
Director pay for 2026 includes a $50,000 to $75,000 cash retainer plus $17,500 in stock, depending on role
Filing states no family relationship with other directors or officers and no related-party transactions over $120,000 since the last fiscal year
DigitalOcean said in a July 7, 2026 press release that it expects Q2 2026 revenue growth of about 29%, up from 14% in the same quarter of 2025, and that its remaining performance obligations will exceed $800 million. The company also expects its adjusted EBITDA margin and non-GAAP net income per share to be at or above the high end of its previously provided guidance. These are preliminary, unaudited figures subject to quarter-end closing adjustments, so final results may differ.
Q2 2026 revenue growth expected at about 29%, versus 14% in Q2 2025
RPO expected to exceed $800 million, up more than $550 million in the quarter
Adjusted EBITDA margin and non-GAAP EPS expected at or above the high end of guidance
Secured an additional 20 MW of data center capacity for late 2027 and early 2028
EchoStar and Hughes Satellite Systems disclosed that Hamid Akhavan, CEO of EchoStar Capital and President and CEO of Hughes, resigned effective immediately on July 6, 2026, following discussions with the board about a change in strategic direction. Charles W. Ergen will take over his responsibilities as Principal Executive Officer of Hughes, and EchoStar Capital will be folded into Corporate Development led by Thomas A. Cullen.
Hamid Akhavan resigned July 6, 2026 from all positions with EchoStar and Hughes, including his board seats, citing a change of strategic direction discussed with the board.
Akhavan will consult with the company through December 31, 2026 to ensure an orderly transition.
Charles W. Ergen takes over as Principal Executive Officer of Hughes; the filing refers to EchoStar's other filings for his compensation and related-party transactions.
Akhavan's option vesting is accelerated from December 31, 2026 to July 6, 2026; EchoStar Capital merges into Corporate Development under Thomas A. Cullen.
Capstone Energy+, Inc. said Nasdaq approved its application to list common stock, and the shares are expected to begin trading under the ticker CEPL on July 8, 2026, moving from OTC Markets. The company said existing shareholders need not take any action, and the filing reports no new financial results.
Nasdaq notified the company on June 30, 2026 that its listing application was approved.
Trading under CEPL is expected to begin July 8, 2026, replacing the OTCQX ticker CGEH.
The 8-K names the Nasdaq Global Market, while the press release names the Nasdaq Global Select Market.
Lazard, Inc. said director Andrew M. Alper retired from its Board, including all committees, effective July 7, 2026, and that Kathy Elsesser, a former Goldman Sachs partner, joined the Board the same day. Ms. Elsesser was also appointed to the Compensation Committee and will chair it once Mr. Alper's retirement takes effect. The filing describes the retirement as not the result of any disagreement with the company.
Andrew M. Alper retired from the Board and its committees, effective July 7, 2026, after more than 13 years of service.
Kathy Elsesser joined the Board effective July 7, 2026, after the Board elected her on July 2, 2026.
Ms. Elsesser joined the Compensation Committee and will chair it upon Mr. Alper's retirement.
Ms. Elsesser also serves on the Board of TPG Inc. and retired from the Goldman Sachs Partnership in 2023.
On June 30, 2026, MeiraGTx entered a royalty note purchase agreement with funds affiliated with Oberland Capital for up to $375 million, secured by company assets and tied to capped royalties on three gene therapy products. The company also agreed to sell 950,570 shares at $10.52 for about $10.0 million and fully redeemed its Perceptive credit notes on the same day. The royalty obligation and asset security add long-term commitments for shareholders, though the funding is non-dilutive apart from the small equity sale.
Initial purchase of $100 million on June 30, 2026, with a second purchase of $25 million scheduled for July 17, 2026
Revenue Payments equal to 1.95% of global net sales of AAV-AIPL1, AAV-hAQP1 and bota-vec, subject to a cap and payable after marketing approval
Sale of 950,570 shares at $10.52 per share for about $10.0 million, with closing on July 17, 2026
Full redemption of Perceptive notes on June 30, 2026, with no early termination penalties
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.